A statistician's perspective on biomarkers in drug development-Reference-Cited by-同舟云学术

A statistician's perspective on biomarkers in drug development

Published:2011-11 Issue:6 Volume:10 Page:494-507
ISSN:1539-1604
Container-title:Pharmaceutical Statistics
language:en
Short-container-title:Pharmaceut. Statist.

Author:

Jenkins Martin¹,Flynn Aiden²,Smart Trevor³,Harbron Chris¹,Sabin Tony⁴,Ratnayake Jayantha⁵,Delmar Paul⁶,Herath Athula⁷,Jarvis Philip¹,Matcham James⁴,

Affiliation:

1. AstraZeneca UK Ltd.; Alderley Park Macclesfield UK

2. Exploristics; Belfast UK

3. Pfizer; Sandwich, Kent UK

4. Amgen Limited; Cambridge Science Park Cambridge UK

5. Roche Products Limited; Shire Park Welwyn Garden City UK

6. Hoffman-La Roche; Basel Switzerland

7. MedImmune; Granta Park Cambridge UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pst.532/fullpdf

Reference109 articles.

1. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework;Atkinson;Clinical Pharmacology and Therapeutics,2001

2. An approach to the validation of markers for the use in AIDS clinical trials;Mildvan;Clinical Infectious Diseases,1997

3. Definitions and validation Criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema;Lassere;Journal of Rheumatology,2007

4. A prototypical process for creating evidentiary standards for biomarkers and diagnostics;Altar;Clinical Pharmacology and Therapeutics,2008

5. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer;De Bono;Clinical Cancer Research,2008

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blinded sample size recalculation in multiple composite population designs with normal data and baseline adjustments;Biometrical Journal;2023-06-12

2. Sample size and performance estimation for biomarker combinations based on pilot studies with small sample sizes;Communications in Statistics - Theory and Methods;2020-11-09

3. Optimized multiple testing procedures for nested sub-populations based on a continuous biomarker;Statistical Methods in Medical Research;2020-03-30

4. Bayesian competing risks analysis without data stratification;Clinical Epidemiology and Global Health;2020-03

5. Is the personalized approach the key to improve clinical diagnosis of peri‐implant conditions? The role of bone markers;Journal of Periodontology;2020-01-20